Table 1. Clinical Features and Genetic Findings for DNAJB6 Mutations.
Genotype | References | Region of study | Onset age | Distribution of weakness | Serum CK | Muscle pathology | Bulbar symptoms |
---|---|---|---|---|---|---|---|
p.Phe89Ile | Kim, et al.4 | Asia | 30–40 | Proximal | NL | N/A | None |
Couthouis, et al.5 | America | 8–18 | Proximal | NL | RV | - | |
Sarparanta, et al.6 | America | 20–55 | Proximal | NL–10× | Myopathic, RV | Yes | |
p.Phe91Ile | Palmio, et al.7 | Europe | 6–13 | Proximal | NL–2× | RV, fibrosis, atrophy, myofibrillar aggregations | None |
Ruggieri, et al.2 | Europe | 16 | Proximal | NL | Dystrophic, RV | None | |
p.Phe91Leu | Nam, et al.1 | Asia | 8–11 | Proximal | NL–2× | RV | None |
Palmio, et al.7 | Europe | 15 | Proximal and distal | NL | RV, Fibrosis, atrophy, myofibrillar aggregations | Yes | |
Ruggieri, et al.2 | Europe | 11 | Proximal | NL | Myopathic, RV | Yes | |
p.Phe93Ile | Sato, et al.8 | Asia | 30s | Proximal | 1.5–5× | Myopathic, RV | None |
p.Phe93Leu | Harm, et al.9 | America | 30–40 | Proximal | 3–6× | Myopathic, RV | None |
Ruggieri, et al.2 | Europe | 45 | Proximal | NL | Myopathic, RV | None | |
p.Ans95Ile | Jonson, et al.3 | Europe | 36–55 | Distal | NL–2× | RV | Yes |
p.Pro96Arg | Harm, et al.9 | African American | 18–35 | Distal | 2× | N/A | None |
p.Pro96Leu | Tsai, et al.10 | Asia | 30–40 | Proximal | NL | Fatty change | Yes |
p.Asp98del | Jonson, et al.3 | Europe | 16, 20 | Proximal and distal | 2× | RV | None |
p.Phe100Val | Ruggieri, et al.2 | Europe | 10–50 | Proximal and distal | 1.5–4× | RV | Yes |
p.Phe100Ile | Kim, et al.4 | Asia | 17, 27 | Proximal and distal | 3× | RV | Yes |
N/A, not available; NL, normal; RV, rimmed vacuole.